Viewing Study NCT05539898



Ignite Creation Date: 2024-05-06 @ 6:04 PM
Last Modification Date: 2024-10-26 @ 2:41 PM
Study NCT ID: NCT05539898
Status: RECRUITING
Last Update Posted: 2023-02-01
First Post: 2022-09-12

Brief Title: Improving the Criteria for Selecting Patients for Primary Prevention of Sudden Cardiac Death by Arrhythmic Risk Stratification
Sponsor: Astrakhan Federal Centre For Cardiac Surgery
Organization: Astrakhan Federal Centre For Cardiac Surgery

Study Overview

Official Title: Improving the Criteria for Selecting Patients for Primary Prevention of Sudden Cardiac Death by Stratification of the Risk of Stable Ventricular Tachyarrhythmias
Status: RECRUITING
Status Verified Date: 2023-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PERFECT
Brief Summary: A number of large randomized studies have demonstrated the importance of left ventricle ejection fraction LV EF for ventrucular tachyarhrythmias VT prediction The use of this indicator as the sole predictor of high arrhythmic risk requiring ICD implantation is enshrined in the current clinical recommendations At the same time many experts consider LV EF as too generalized indicator which can be an integral indicator of total cardiovascular mortality but lacks specificity in determining the risk of VT It is known that only about 20 of patients with ICD implanted for primary prevention of sudden cardiac death SCD receive appropriate life-saving therapy

Purpose of the study to develop additional criteria for selection of patients with heart failure for implantation of cardioverter-defibrillator for the purpose of primary SCD prevention on the basis of stratification of the risk of occurrence of stable ventricular tachyarrhythmias
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None